These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21899894)

  • 1. Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies.
    Pericleous C; Miles J; Esposito D; Garza-Garcia A; Driscoll PC; Lambrianides A; Latchman D; Isenberg D; Rahman A; Ioannou Y; Giles I
    Mol Immunol; 2011 Oct; 49(1-2):56-63. PubMed ID: 21899894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43.
    Ioannou Y; Pericleous C; Giles I; Latchman DS; Isenberg DA; Rahman A
    Arthritis Rheum; 2007 Jan; 56(1):280-90. PubMed ID: 17195232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Michael Mason Prize: Pathogenic antiphospholipid antibodies, stressed out antigens and the deployment of decoys.
    Ioannou Y
    Rheumatology (Oxford); 2012 Jan; 51(1):32-6. PubMed ID: 22120465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli.
    Ioannou Y; Giles I; Lambrianides A; Richardson C; Pearl LH; Latchman DS; Isenberg DA; Rahman A
    BMC Biotechnol; 2006 Feb; 6():8. PubMed ID: 16472380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain I of beta2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome.
    Ioannou Y; Rahman A
    Lupus; 2010 Apr; 19(4):400-5. PubMed ID: 20353977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.
    Tonello M; Mattia E; Del Ross T; Favaro M; Calligaro A; Hoxha A; Bison E; Pengo V; Ruffatti A
    Clin Chim Acta; 2018 Oct; 485():74-78. PubMed ID: 29953850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS).
    Banzato A; Pozzi N; Frasson R; De Filippis V; Ruffatti A; Bison E; Padayattil SJ; Denas G; Pengo V
    Thromb Res; 2011 Dec; 128(6):583-6. PubMed ID: 21620443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome.
    McDonnell TCR; Willis R; Pericleous C; Ripoll VM; Giles IP; Isenberg DA; Brasier AR; Gonzalez EB; Papalardo E; Romay-Penabad Z; Jamaluddin M; Ioannou Y; Rahman A
    Front Immunol; 2018; 9():2413. PubMed ID: 30405613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept.
    Ioannou Y; Romay-Penabad Z; Pericleous C; Giles I; Papalardo E; Vargas G; Shilagard T; Latchman DS; Isenberg DA; Rahman A; Pierangeli S
    J Thromb Haemost; 2009 May; 7(5):833-42. PubMed ID: 19220729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
    Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
    Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens.
    Giles I; Lambrianides N; Pattni N; Faulkes D; Latchman D; Chen P; Pierangeli S; Isenberg D; Rahman A
    J Immunol; 2006 Aug; 177(3):1729-36. PubMed ID: 16849482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipin.
    Giles IP; Haley J; Nagl S; Latchman DS; Chen PP; Chukwuocha RU; Isenberg DA; Rahman A
    Mol Immunol; 2003 Sep; 40(1):49-60. PubMed ID: 12909130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies.
    Chighizola CB; Gerosa M; Meroni PL
    Curr Rheumatol Rep; 2014 Feb; 16(2):402. PubMed ID: 24390756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
    Ostertag MV; Liu X; Henderson V; Pierangeli SS
    Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An allosteric redox switch in domain V of β
    Kumar S; Chinnaraj M; Planer W; Zuo X; Macor P; Tedesco F; Pozzi N
    J Biol Chem; 2021 Aug; 297(2):100890. PubMed ID: 34197876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
    Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
    Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.